cardiac safety

/Tag: cardiac safety

Safety Pharmacology Society (SPS) Annual Meeting 2019


Metrion Biosciences' Business Manager Dr John Ridley, Head of Client Research Services, Dr Robert Kirby and Senior Scientist, Dr Edward Humphries will be attending, presenting posters and exhibiting at the Safety Pharmacology Society (SPS) Annual Meeting. The event is to be held at the Centre de Convencions Internacional de Barcelona between 23rd and 26th September [...]

Safety Pharmacology Society (SPS) Annual Meeting 20192019-09-05T10:49:08+00:00

Nav1.5(Late) Cardiac Safety Assay on QPatch


The Metrion Biosciences team have recently produced a second application note in collaboration with Sophion Bioscience, describing the use of a ∆KPQ LQT3 mutant to create and validate a Nav1.5 (Late) cardiac safety assay on QPatch 48. Herein, we aim to provide a more reliable and accurate Nav1.5(Late) assay, which removes the requirement for costly [...]

Nav1.5(Late) Cardiac Safety Assay on QPatch2019-09-02T13:16:05+00:00

A summary of the Sixth Cambridge Ion Channel Forum


AstraZeneca and Metrion Biosciences again joined forces on April 9 to co-host the 6th Cambridge Ion Channel Forum, held at the Milstein building at Granta Park. The event has been a key feature of the ion channel enthusiasts’ calendar since 2011 and attended by around 65 delegates, who also enjoyed a networking lunch and poster [...]

A summary of the Sixth Cambridge Ion Channel Forum2019-08-28T09:14:56+00:00

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX


Metrion Biosciences are sponsoring this years' Biophysical Society Satellite event 'Drug Discovery for Ion Channels XIX' in Baltimore on Friday 1st March 2019. Metrion's CSO Dr Marc Rogers and Sales and Marketing Manager Dr Sophie Rose will be attending. Marc Rogers will be presenting "Successful Development of State-dependent Voltage-gated Ion Channel Modulators with in vivo [...]

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX2019-02-06T16:12:06+00:00

ACEA European Cardio Symposium


Metrion Biosciences' will be attending and presenting at the ACEA Biosciences European Cardio Symposium in Cambridge, UK. Metrion's Dr Saïd El Haou will be presenting a talk. The title of our presentation will be announced shortly. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest [...]

ACEA European Cardio Symposium2018-08-29T12:49:55+00:00

Cambridge Ion Channel Forum


Metrion Biosciences and AstraZeneca joined forces on Tuesday 8th May 2018 to co-host the fifth Cambridge Ion Channel Forum at Medimmune’s Milstein Building on Granta Park, Cambridge (UK). Established in 2011, with previous co-organisers including Neusentis, Medimmune and BioFocus, this afternoon session of ion channel focused presentations provides an opportunity for delegates to participate [...]

Cambridge Ion Channel Forum2018-07-18T16:01:59+00:00